Corticosteroids for high‐grade immune checkpoint inhibitor–mediated hepatitis: Is less more?
Jason J. Pan, Nataliya Razumilava – 9 January 2022
Letter to the editor: Relevance of population‐based cutoffs to define frailty in clinical studies
Shweta A. Singh, Kaushal Madan, Subhash Gupta, Abhaya Indrayan – 9 January 2022
Outside influence: The extrahepatic duct as a source for bile duct regeneration
Emma R. Andersson – 9 January 2022
Microwave ablation versus laparoscopic resection as first‐line therapy for solitary 3–5‐cm HCC
Zhen Wang, Miao Liu, De‐zhi Zhang, Song‐song Wu, Zhi‐xian Hong, Guang‐bin He, Hong Yang, Bang‐de Xiang, Xiao Li, Tian‐an Jiang, Kai Li, Zhe Tang, Fei Huang, Man Lu, Ji‐an Chen, Yu‐cheng Lin, Xiao Lu, Yu‐quan Wu, Xiao‐wu Zhang, Ye‐fan Zhang, Chao Cheng, Huo‐lin Ye, Lan‐tian Wang, Hua‐ge Zhong, Jian‐hong Zhong, Lu Wang, Miao Chen, Fang‐fang Liang, Yi Chen, Yan‐song Xu, Xiao‐ling Yu, Zhi‐gang Cheng, Fang‐yi Liu, Zhi‐yu Han, Wei‐zhong Tang, Jie Yu, Ping Liang – 9 January 2022
The RSPO‐LGR4/5‐ZNRF3/RNF43 module in liver homeostasis, regeneration, and disease
Stefano Annunziato, Tianliang Sun, Jan S. Tchorz – 9 January 2022 – WNT/β‐catenin signaling plays pivotal roles during liver development, homeostasis, and regeneration. Likewise, its deregulation disturbs metabolic liver zonation and is responsible for the development of a large number of hepatic tumors. Liver fibrosis, which has become a major health burden for society and a hallmark of NASH, can also be promoted by WNT/β‐catenin signaling.
Notch‐triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase
Zhi‐Qiang Fang, Bai Ruan, Jing‐Jing Liu, Juan‐Li Duan, Zhen‐Sheng Yue, Ping Song, Hao Xu, Jian Ding, Chen Xu, Guo‐Rui Dou, Lin Wang – 9 January 2022
Disrupted BRCA1‐PALB2 interaction induces tumor immunosuppression and T‐lymphocyte infiltration in HCC through cGAS‐STING pathway
Hui Ma, Zhihua Kang, Tzeh Keong Foo, Zhiyuan Shen, Bing Xia – 9 January 2022
Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humans
Sumedha Gunewardena, Ian Huck, Chad Walesky, Dakota Robarts, Steven Weinman, Udayan Apte – 9 January 2022
The Current Landscape of Liver Transplantation After Ex Situ Machine Perfusion and Normothermic Regional Perfusion in the United States
Kristopher P. Croome, Shennen Mao, C. Burcin Taner – 8 January 2022
Pediatric NASH therapies: A speedbump on the road to success
Samir Softic, Rohit Kohli – 8 January 2022